4
Changes in Ownership
Elicio Therapeutics, Inc. Filed Acc 0001140361-24-005496
Options or other derivatives
- Chief Scientific Officer acquired 30,142 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DeMuth Peter · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +29,800 | 29,800 | D |
| 2024-02-01 | Grant or award : show line 2 in the form Stock Option (right to buy) | +342 | 342 | D |
Loading xslF345X05/form4.xml…